Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety.

Madhi, Shabir A

Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jan 2011 - 128-37 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1537-6591

10.1093/cid/ciq004 doi


Adolescent
Adult
Anti-HIV Agents--administration & dosage
Antibodies, Viral--blood
Antiretroviral Therapy, Highly Active--methods
Double-Blind Method
Female
HIV Infections--drug therapy
Hemagglutination Inhibition Tests
Humans
Influenza A Virus, H1N1 Subtype--growth & development
Influenza A Virus, H3N2 Subtype--growth & development
Influenza B virus--growth & development
Influenza Vaccines--administration & dosage
Influenza, Human--immunology
Male
Middle Aged
Oropharynx--virology
Placebos--administration & dosage
RNA, Viral--genetics
Reverse Transcriptase Polymerase Chain Reaction
South Africa
Treatment Outcome
Vaccines, Inactivated--administration & dosage
Virus Cultivation
Young Adult